Gut Health
FDA Approves New Narcolepsy Treatment
Seraphina Wentworth · August 24, 2026
FDA approves new narcolepsy treatment targeting orexin deficiency for narcolepsy type 1 patients.
01
02
03
04
05
FDA approves new narcolepsy treatment targeting orexin deficiency for narcolepsy type 1 patients.
FDA approves new narcolepsy treatment targeting orexin deficiency for narcolepsy type 1 patients.
Global study reveals significant challenges in managing leukemia therapies and care capabilities across different countries and clinical settings.
The tragic death of an uninsured patient exposes a charity care gap in the U.S., where essential outpatient…
Newsom signs legislation for California teachers, providing up to 14 weeks of paid pregnancy leave. Read the latest…
Health gains are slowing under Trump policies, affecting communities like Dewey City with poor living conditions and health…
Trump administration pushes hospitals to release ER patient data, raising major privacy concerns among legal and health experts.
More Than Just Entertainment For years, video games were often criticized for being little more than a distraction.…
Tariffs on imported generic drugs may raise drug safety costs for patients, affecting the nation's drug supply.
Police brutality concerns resurface after new death of Lloyd Gilmore, who had mental health issues, in police custody…
As housing costs rise, older adults are embracing the 'Golden Girls' housing model to stay safe and independent…
